Global Transplant Monitoring Kits Market Insights, Growth, Share, Size: By Technology Type, By Product, By Application, By Transplant Type, By End User, By Region & Segmental Forecast, 2023-2031, Comparative Analysis and Trends
Global Transplant Monitoring Kits Market was Valued at USD 4.82 Billion in 2022, Growing at an Estimated CAGR of 4.8% from 2023-2031.
Transplant monitoring kits are specialized diagnostic tools designed to assess the health and status of transplanted organs or tissues. These kits utilize advanced molecular and immunological techniques to detect potential complications, rejection, or infections post-transplantation. By analyzing specific biomarkers, gene expression, or immune response, these kits provide clinicians with valuable insights into the graft's well-being. These kits play a crucial role in improving transplant outcomes, enhancing patient safety, and reducing the risk of graft rejection. They serve as vital tools for monitoring the success and long-term viability of transplanted organs, ultimately benefiting the patients and optimizing post-transplant care.
COVID-19 Impact Analysis on Global Transplant Monitoring Kits Market
Many elective medical procedures, including organ transplants, were postponed or canceled during the pandemic's peak to allocate resources to COVID-19 patients. This led to a reduced demand for transplant monitoring kits, as fewer transplants were performed. However, the transplant monitoring kits market is expected to recover in the long term, as the demand for organ transplants and transplant monitoring kits is expected to increase.
Global Transplant Monitoring Kits Market Revenue & Forecast, (US$ Million), 2015 – 2031
Molecular assay technologies have been dominating the global transplant monitoring kits market. These techniques, including polymerase chain reaction (PCR) and quantitative PCR (qPCR), enable highly sensitive and specific detection of genetic and molecular markers associated with graft health. The precision of molecular assays has made them a primary choice for transplant monitoring due to their ability to detect early signs of rejection or complications.
The rising global burden of organ failure and chronic diseases drives the need for transplant monitoring kits. Globally, nearly 150,000 solid organ transplants were done in 2022, according to the Global Observatory on Donation and Transplantation. As the demand for organs continues to grow, efficient monitoring becomes vital to ensure graft health and patient outcomes, propelling the demand for monitoring kits. The complex and dynamic nature of immune responses in transplant recipients poses a challenge. According to a study, it has been highlighted the intricate immunological interactions involved in graft acceptance and rejection. The multifaceted nature of these responses complicates the development of universally applicable transplant monitoring kits, potentially limiting their effectiveness across various patient profiles and transplant types.
Solid organ transplants, such as kidney, liver, heart, and lung transplants, dominate the transplant monitoring kits market. According to the World Health Organization (WHO), over 140,000 solid organ transplants were performed globally in 2022. These procedures have a well-established demand for monitoring due to the critical nature of organ functionality post-transplant.
North America dominated the global transplant monitoring kits market in 2022. In the US alone, more than 40,000 organ transplants were performed annually. This dominance is attributed to advanced healthcare infrastructure, established transplant centers, and a robust biopharmaceutical industry. Additionally, North America hosts several leading medical research institutions that drive innovation in transplantation and monitoring technologies.
Competitive Landscape
The report provides both, qualitative and quantitative research of global transplant monitoring kits market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global transplant monitoring kits market are
- Biocare Health Resources, Inc.
- Biogenuix Medsystems Pvt. Ltd
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- ELITech Group
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- Genome Diagnostics B.V.
- Hologic, Inc.
- JETA Molecular BV.
- Natera, Inc.
- QIAGEN
- SanBio Co,Ltd.
- Thermo Fisher Scientific Inc.
- Other Industry Participants
Global Transplant Monitoring Kits Market
By Technology Type
- Molecular Assay Technologies
- PCR-based Molecular Assays
- Real-time PCR
- Sequence Specific Primers-PCR
- Sequence-Specific Oligonucleotide-PCR
- Others
- Sequencing-based Molecular Assays
- PCR-based Molecular Assays
- Sanger Sequencing
- Non-molecular Assay Technologies
By Product
- Reagents & Consumables
- Instruments
- Software & Services
By Application
- Diagnostic Applications
- Research Applications
By Transplant Type
- Solid Organ
- Stem Cell
- Soft Tissue
By End User
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 – 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Transplant Monitoring Kits Market
6. Market Synopsis:
Transplant Monitoring Kits Market
7. Transplant Monitoring Kits Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Transplant Monitoring Kits Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Transplant Monitoring Kits Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Transplant Monitoring Kits Market
8. Global Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
8.1. Overview
8.1.1. Global
Transplant Monitoring Kits Market Revenue (US$ Mn)
8.2. Global
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Technology
Type
8.2.1. Molecular
Assay Technologies (Definition, Market Estimation and Penetration, 2015 - 2022,
Market Estimation (2015 - 2022), Market Forecast (2023 – 2031), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on PCR-based Molecular
Assays , Sequencing-based Molecular Assays)
8.2.1.1. PCR-based Molecular Assays
8.2.1.1.1. Real-time PCR
8.2.1.1.2. Sequence Specific Primers-PCR
8.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
8.2.1.1.4. Others
8.2.1.2. Sequencing-based Molecular Assays
8.2.2. Sanger
Sequencing
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.2.3. Non-molecular
Assay Technologies
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 - 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 - 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 - 2031
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 - 2031
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 - 2031
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By
Technology Type
9. Global Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
9.1. Overview
9.2. Global
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Product
9.2.1. Reagents
and Consumables
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. Instruments
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.2.3. Software
and Services
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Product
10. Global Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
10.1. Overview
10.2. Global
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Diagnostic
Applications
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Research
Applications
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
11.1. Overview
11.2. Global
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Transplant
Type
11.2.1. Solid
Organ
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. Stem
Cell
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3. Soft
Tissue
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By
Transplant Type
12. Global Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
12.1. Overview
12.2. Global
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By End User
12.2.1. Independent
Reference Laboratories
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2022
12.2.1.3. Market Forecast, 2023 - 2031
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2022
12.2.1.5.1.2. Market
Forecast, 2023 - 2031
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2022
12.2.1.5.2.2. Market
Forecast, 2023 - 2031
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2022
12.2.1.5.3.2. Market
Forecast, 2023 - 2031
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2022
12.2.1.5.4.2. Market
Forecast, 2023 - 2031
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2022
12.2.1.5.5.2. Market
Forecast, 2023 - 2031
12.2.2. Hospitals
and Transplant Centers
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2022
12.2.2.3. Market Forecast, 2023 - 2031
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2022
12.2.2.5.1.2. Market
Forecast, 2023 - 2031
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2022
12.2.2.5.2.2. Market
Forecast, 2023 - 2031
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2022
12.2.2.5.3.2. Market
Forecast, 2023 - 2031
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2022
12.2.2.5.4.2. Market
Forecast, 2023 - 2031
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2022
12.2.2.5.5.2. Market
Forecast, 2023 - 2031
12.2.3. Research
Laboratories and Academic Institutes
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 - 2022
12.2.3.3. Market Forecast, 2023 - 2031
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market
Estimation, 2015 - 2022
12.2.3.5.1.2. Market
Forecast, 2023 - 2031
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2022
12.2.3.5.2.2. Market
Forecast, 2023 - 2031
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2022
12.2.3.5.3.2. Market
Forecast, 2023 - 2031
12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2022
12.2.3.5.4.2. Market
Forecast, 2023 - 2031
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market
Estimation, 2015 - 2022
12.2.3.5.5.2. Market
Forecast, 2023 - 2031
12.3. Key
Segment for Channeling Investments
12.3.1. By End
User
13. North America Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
13.1. Overview
13.1.1. North
America Transplant Monitoring Kits Market Revenue (US$ Mn)
13.2. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Technology Type
13.2.1. Molecular
Assay Technologies
13.2.1.1. PCR-based Molecular Assays
13.2.1.1.1. Real-time PCR
13.2.1.1.2. Sequence Specific Primers-PCR
13.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
13.2.1.1.4. Others
13.2.1.2. Sequencing-based Molecular Assays
13.2.2. Sanger
Sequencing
13.2.3. Non-molecular
Assay Technologies
13.3. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Product
13.3.1. Reagents
and Consumables
13.3.2. Instruments
13.3.3. Software
and Services
13.4. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Diagnostic
Applications
13.4.2. Research
Applications
13.5. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Transplant Type
13.5.1. Solid
Organ
13.5.2. Stem
Cell
13.5.3. Soft
Tissue
13.6. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
End User
13.6.1. Independent
Reference Laboratories
13.6.2. Hospitals
and Transplant Centers
13.6.3. Research
Laboratories and Academic Institutes
13.7. North
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Country
13.7.1. U.S
13.7.1.1. U.S Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
13.7.1.1.1. Molecular Assay Technologies
13.7.1.1.1.1. PCR-based
Molecular Assays
13.7.1.1.1.1.1. Real-time PCR
13.7.1.1.1.1.2. Sequence Specific Primers-PCR
13.7.1.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
13.7.1.1.1.1.4. Others
13.7.1.1.1.2. Sequencing-based
Molecular Assays
13.7.1.1.2. Sanger Sequencing
13.7.1.1.3. Non-molecular Assay Technologies
13.7.1.2. U.S Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
13.7.1.2.1. Reagents and Consumables
13.7.1.2.2. Instruments
13.7.1.2.3. Software and Services
13.7.1.3. U.S Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.1.3.1. Diagnostic Applications
13.7.1.3.2. Research Applications
13.7.1.4. U.S Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
13.7.1.4.1. Solid Organ
13.7.1.4.2. Stem Cell
13.7.1.4.3. Soft Tissue
13.7.1.5. U.S Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
13.7.1.5.1. Independent Reference Laboratories
13.7.1.5.2. Hospitals and Transplant Centers
13.7.1.5.3. Research Laboratories and Academic Institutes
13.7.2. Canada
13.7.2.1. Canada Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
13.7.2.1.1. Molecular Assay Technologies
13.7.2.1.1.1. PCR-based
Molecular Assays
13.7.2.1.1.1.1. Real-time PCR
13.7.2.1.1.1.2. Sequence Specific Primers-PCR
13.7.2.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
13.7.2.1.1.1.4. Others
13.7.2.1.1.2. Sequencing-based
Molecular Assays
13.7.2.1.2. Sanger Sequencing
13.7.2.1.3. Non-molecular Assay Technologies
13.7.2.2. Canada Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
13.7.2.2.1. Reagents and Consumables
13.7.2.2.2. Instruments
13.7.2.2.3. Software and Services
13.7.2.3. Canada Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.2.3.1. Diagnostic Applications
13.7.2.3.2. Research Applications
13.7.2.4. Canada Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
13.7.2.4.1. Solid Organ
13.7.2.4.2. Stem Cell
13.7.2.4.3. Soft Tissue
13.7.2.5. Canada Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
13.7.2.5.1. Independent Reference Laboratories
13.7.2.5.2. Hospitals and Transplant Centers
13.7.2.5.3. Research Laboratories and Academic Institutes
13.7.3. Mexico
13.7.3.1. Mexico Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
13.7.3.1.1. Molecular Assay Technologies
13.7.3.1.1.1. PCR-based
Molecular Assays
13.7.3.1.1.1.1. Real-time PCR
13.7.3.1.1.1.2. Sequence Specific Primers-PCR
13.7.3.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
13.7.3.1.1.1.4. Others
13.7.3.1.1.2. Sequencing-based
Molecular Assays
13.7.3.1.2. Sanger Sequencing
13.7.3.1.3. Non-molecular Assay Technologies
13.7.3.2. Mexico Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
13.7.3.2.1. Reagents and Consumables
13.7.3.2.2. Instruments
13.7.3.2.3. Software and Services
13.7.3.3. Mexico Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.3.3.1. Diagnostic Applications
13.7.3.3.2. Research Applications
13.7.3.4. Mexico Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
13.7.3.4.1. Solid Organ
13.7.3.4.2. Stem Cell
13.7.3.4.3. Soft Tissue
13.7.3.5. Mexico Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
13.7.3.5.1. Independent Reference Laboratories
13.7.3.5.2. Hospitals and Transplant Centers
13.7.3.5.3. Research Laboratories and Academic Institutes
13.7.4. Rest of
North America
13.7.4.1. Rest of North America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Technology Type
13.7.4.1.1. Molecular Assay Technologies
13.7.4.1.1.1. PCR-based
Molecular Assays
13.7.4.1.1.1.1. Real-time PCR
13.7.4.1.1.1.2. Sequence Specific Primers-PCR
13.7.4.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
13.7.4.1.1.1.4. Others
13.7.4.1.1.2. Sequencing-based
Molecular Assays
13.7.4.1.2. Sanger Sequencing
13.7.4.1.3. Non-molecular Assay Technologies
13.7.4.2. Rest of North America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Product
13.7.4.2.1. Reagents and Consumables
13.7.4.2.2. Instruments
13.7.4.2.3. Software and Services
13.7.4.3. Rest of North America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Application
13.7.4.3.1. Diagnostic Applications
13.7.4.3.2. Research Applications
13.7.4.4. Rest of North America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Transplant Type
13.7.4.4.1. Solid Organ
13.7.4.4.2. Stem Cell
13.7.4.4.3. Soft Tissue
13.7.4.5. Rest of North America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By End User
13.7.4.5.1. Independent Reference Laboratories
13.7.4.5.2. Hospitals and Transplant Centers
13.7.4.5.3. Research Laboratories and Academic Institutes
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Technology Type
13.8.3. By
Product
13.8.4. By
Application
13.8.5. By
Transplant Type
13.8.6. By End
User
14. Europe Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
14.1. Overview
14.1.1. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn)
14.2. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Technology
Type
14.2.1. Molecular
Assay Technologies
14.2.1.1. PCR-based Molecular Assays
14.2.1.1.1. Real-time PCR
14.2.1.1.2. Sequence Specific Primers-PCR
14.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.2.1.1.4. Others
14.2.1.2. Sequencing-based Molecular Assays
14.2.2. Sanger
Sequencing
14.2.3. Non-molecular
Assay Technologies
14.3. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Product
14.3.1. Reagents
and Consumables
14.3.2. Instruments
14.3.3. Software
and Services
14.4. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Diagnostic
Applications
14.4.2. Research
Applications
14.5. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Transplant
Type
14.5.1. Solid
Organ
14.5.2. Stem
Cell
14.5.3. Soft
Tissue
14.6. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By End User
14.6.1. Independent
Reference Laboratories
14.6.2. Hospitals
and Transplant Centers
14.6.3. Research
Laboratories and Academic Institutes
14.7. Europe
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
14.7.1.1.1. Molecular Assay Technologies
14.7.1.1.1.1. PCR-based
Molecular Assays
14.7.1.1.1.1.1. Real-time PCR
14.7.1.1.1.1.2. Sequence Specific Primers-PCR
14.7.1.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.1.1.1.1.4. Others
14.7.1.1.1.2. Sequencing-based
Molecular Assays
14.7.1.1.2. Sanger Sequencing
14.7.1.1.3. Non-molecular Assay Technologies
14.7.1.2. France Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
14.7.1.2.1. Reagents and Consumables
14.7.1.2.2. Instruments
14.7.1.2.3. Software and Services
14.7.1.3. France Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.1.3.1. Diagnostic Applications
14.7.1.3.2. Research Applications
14.7.1.4. France Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
14.7.1.4.1. Solid Organ
14.7.1.4.2. Stem Cell
14.7.1.4.3. Soft Tissue
14.7.1.5. France Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.1.5.1. Independent Reference Laboratories
14.7.1.5.2. Hospitals and Transplant Centers
14.7.1.5.3. Research Laboratories and Academic Institutes
14.7.2. The UK
14.7.2.1. The UK Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
14.7.2.1.1. Molecular Assay Technologies
14.7.2.1.1.1. PCR-based
Molecular Assays
14.7.2.1.1.1.1. Real-time PCR
14.7.2.1.1.1.2. Sequence Specific Primers-PCR
14.7.2.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.2.1.1.1.4. Others
14.7.2.1.1.2. Sequencing-based
Molecular Assays
14.7.2.1.2. Sanger Sequencing
14.7.2.1.3. Non-molecular Assay Technologies
14.7.2.2. The UK Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
14.7.2.2.1. Reagents and Consumables
14.7.2.2.2. Instruments
14.7.2.2.3. Software and Services
14.7.2.3. The UK Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.2.3.1. Diagnostic Applications
14.7.2.3.2. Research Applications
14.7.2.4. The UK Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
14.7.2.4.1. Solid Organ
14.7.2.4.2. Stem Cell
14.7.2.4.3. Soft Tissue
14.7.2.5. The UK Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.2.5.1. Independent Reference Laboratories
14.7.2.5.2. Hospitals and Transplant Centers
14.7.2.5.3. Research Laboratories and Academic Institutes
14.7.3. Spain
14.7.3.1. Spain Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
14.7.3.1.1. Molecular Assay Technologies
14.7.3.1.1.1. PCR-based
Molecular Assays
14.7.3.1.1.1.1. Real-time PCR
14.7.3.1.1.1.2. Sequence Specific Primers-PCR
14.7.3.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.3.1.1.1.4. Others
14.7.3.1.1.2. Sequencing-based
Molecular Assays
14.7.3.1.2. Sanger Sequencing
14.7.3.1.3. Non-molecular Assay Technologies
14.7.3.2. Spain Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
14.7.3.2.1. Reagents and Consumables
14.7.3.2.2. Instruments
14.7.3.2.3. Software and Services
14.7.3.3. Spain Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.3.3.1. Diagnostic Applications
14.7.3.3.2. Research Applications
14.7.3.4. Spain Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
14.7.3.4.1. Solid Organ
14.7.3.4.2. Stem Cell
14.7.3.4.3. Soft Tissue
14.7.3.5. Spain Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.3.5.1. Independent Reference Laboratories
14.7.3.5.2. Hospitals and Transplant Centers
14.7.3.5.3. Research Laboratories and Academic Institutes
14.7.4. Germany
14.7.4.1. Germany Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
14.7.4.1.1. Molecular Assay Technologies
14.7.4.1.1.1. PCR-based
Molecular Assays
14.7.4.1.1.1.1. Real-time PCR
14.7.4.1.1.1.2. Sequence Specific Primers-PCR
14.7.4.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.4.1.1.1.4. Others
14.7.4.1.1.2. Sequencing-based
Molecular Assays
14.7.4.1.2. Sanger Sequencing
14.7.4.1.3. Non-molecular Assay Technologies
14.7.4.2. Germany Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
14.7.4.2.1. Reagents and Consumables
14.7.4.2.2. Instruments
14.7.4.2.3. Software and Services
14.7.4.3. Germany Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.4.3.1. Diagnostic Applications
14.7.4.3.2. Research Applications
14.7.4.4. Germany Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
14.7.4.4.1. Solid Organ
14.7.4.4.2. Stem Cell
14.7.4.4.3. Soft Tissue
14.7.4.5. Germany Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.4.5.1. Independent Reference Laboratories
14.7.4.5.2. Hospitals and Transplant Centers
14.7.4.5.3. Research Laboratories and Academic Institutes
14.7.5. Italy
14.7.5.1. Italy Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
14.7.5.1.1. Molecular Assay Technologies
14.7.5.1.1.1. PCR-based
Molecular Assays
14.7.5.1.1.1.1. Real-time PCR
14.7.5.1.1.1.2. Sequence Specific Primers-PCR
14.7.5.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.5.1.1.1.4. Others
14.7.5.1.1.2. Sequencing-based
Molecular Assays
14.7.5.1.2. Sanger Sequencing
14.7.5.1.3. Non-molecular Assay Technologies
14.7.5.2. Italy Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
14.7.5.2.1. Reagents and Consumables
14.7.5.2.2. Instruments
14.7.5.2.3. Software and Services
14.7.5.3. Italy Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.5.3.1. Diagnostic Applications
14.7.5.3.2. Research Applications
14.7.5.4. Italy Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
14.7.5.4.1. Solid Organ
14.7.5.4.2. Stem Cell
14.7.5.4.3. Soft Tissue
14.7.5.5. Italy Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.5.5.1. Independent Reference Laboratories
14.7.5.5.2. Hospitals and Transplant Centers
14.7.5.5.3. Research Laboratories and Academic Institutes
14.7.6. Nordic
Countries
14.7.6.1. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Technology Type
14.7.6.1.1. Molecular Assay Technologies
14.7.6.1.1.1. PCR-based
Molecular Assays
14.7.6.1.1.1.1. Real-time PCR
14.7.6.1.1.1.2. Sequence Specific Primers-PCR
14.7.6.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.6.1.1.1.4. Others
14.7.6.1.1.2. Sequencing-based
Molecular Assays
14.7.6.1.2. Sanger Sequencing
14.7.6.1.3. Non-molecular Assay Technologies
14.7.6.2. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Product
14.7.6.2.1. Reagents and Consumables
14.7.6.2.2. Instruments
14.7.6.2.3. Software and Services
14.7.6.3. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Application
14.7.6.3.1. Diagnostic Applications
14.7.6.3.2. Research Applications
14.7.6.4. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Transplant Type
14.7.6.4.1. Solid Organ
14.7.6.4.2. Stem Cell
14.7.6.4.3. Soft Tissue
14.7.6.5. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By End User
14.7.6.5.1. Independent Reference Laboratories
14.7.6.5.2. Hospitals and Transplant Centers
14.7.6.5.3. Research Laboratories and Academic Institutes
14.7.6.6. Nordic Countries Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Technology Type
14.7.7.1.1. Molecular Assay Technologies
14.7.7.1.1.1. PCR-based
Molecular Assays
14.7.7.1.1.1.1. Real-time PCR
14.7.7.1.1.1.2. Sequence Specific Primers-PCR
14.7.7.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.7.1.1.1.4. Others
14.7.7.1.1.2. Sequencing-based
Molecular Assays
14.7.7.1.2. Sanger Sequencing
14.7.7.1.3. Non-molecular Assay Technologies
14.7.7.2. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Product
14.7.7.2.1. Reagents and Consumables
14.7.7.2.2. Instruments
14.7.7.2.3. Software and Services
14.7.7.3. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Application
14.7.7.3.1. Diagnostic Applications
14.7.7.3.2. Research Applications
14.7.7.4. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Transplant Type
14.7.7.4.1. Solid Organ
14.7.7.4.2. Stem Cell
14.7.7.4.3. Soft Tissue
14.7.7.5. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By End User
14.7.7.5.1. Independent Reference Laboratories
14.7.7.5.2. Hospitals and Transplant Centers
14.7.7.5.3. Research Laboratories and Academic Institutes
14.7.7.6. Benelux Union Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest of Europe Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Technology Type
14.7.8.1.1. Molecular Assay Technologies
14.7.8.1.1.1. PCR-based
Molecular Assays
14.7.8.1.1.1.1. Real-time PCR
14.7.8.1.1.1.2. Sequence Specific Primers-PCR
14.7.8.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
14.7.8.1.1.1.4. Others
14.7.8.1.1.2. Sequencing-based
Molecular Assays
14.7.8.1.2. Sanger Sequencing
14.7.8.1.3. Non-molecular Assay Technologies
14.7.8.2. Rest of Europe Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Product
14.7.8.2.1. Reagents and Consumables
14.7.8.2.2. Instruments
14.7.8.2.3. Software and Services
14.7.8.3. Rest of Europe Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Application
14.7.8.3.1. Diagnostic Applications
14.7.8.3.2. Research Applications
14.7.8.4. Rest of Europe Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Transplant Type
14.7.8.4.1. Solid Organ
14.7.8.4.2. Stem Cell
14.7.8.4.3. Soft Tissue
14.7.8.5. Rest of Europe Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By End User
14.7.8.5.1. Independent Reference Laboratories
14.7.8.5.2. Hospitals and Transplant Centers
14.7.8.5.3. Research Laboratories and Academic Institutes
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Technology Type
14.8.3. By
Product
14.8.4. By
Application
14.8.5. By
Transplant Type
14.8.6. By End
User
15. Asia Pacific Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
15.1. Overview
15.1.1. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn)
15.2. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Technology Type
15.2.1. Molecular
Assay Technologies
15.2.1.1. PCR-based Molecular Assays
15.2.1.1.1. Real-time PCR
15.2.1.1.2. Sequence Specific Primers-PCR
15.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.2.1.1.4. Others
15.2.1.2. Sequencing-based Molecular Assays
15.2.2. Sanger
Sequencing
15.2.3. Non-molecular
Assay Technologies
15.3. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Product
15.3.1. Reagents
and Consumables
15.3.2. Instruments
15.3.3. Software
and Services
15.4. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Application
15.4.1. Diagnostic
Applications
15.4.2. Research
Applications
15.5. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Transplant Type
15.5.1. Solid
Organ
15.5.2. Stem
Cell
15.5.3. Soft
Tissue
15.6. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
End User
15.6.1. Independent
Reference Laboratories
15.6.2. Hospitals
and Transplant Centers
15.6.3. Research
Laboratories and Academic Institutes
15.7. Asia
Pacific Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Country
15.7.1. China
15.7.1.1. China Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
15.7.1.1.1. Molecular Assay Technologies
15.7.1.1.1.1. PCR-based
Molecular Assays
15.7.1.1.1.1.1. Real-time PCR
15.7.1.1.1.1.2. Sequence Specific Primers-PCR
15.7.1.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.1.1.1.1.4. Others
15.7.1.1.1.2. Sequencing-based
Molecular Assays
15.7.1.1.2. Sanger Sequencing
15.7.1.1.3. Non-molecular Assay Technologies
15.7.1.2. China Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
15.7.1.2.1. Reagents and Consumables
15.7.1.2.2. Instruments
15.7.1.2.3. Software and Services
15.7.1.3. China Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.1.3.1. Diagnostic Applications
15.7.1.3.2. Research Applications
15.7.1.4. China Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
15.7.1.4.1. Solid Organ
15.7.1.4.2. Stem Cell
15.7.1.4.3. Soft Tissue
15.7.1.5. China Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
15.7.1.5.1. Independent Reference Laboratories
15.7.1.5.2. Hospitals and Transplant Centers
15.7.1.5.3. Research Laboratories and Academic Institutes
15.7.2. Japan
15.7.2.1. Japan Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
15.7.2.1.1. Molecular Assay Technologies
15.7.2.1.1.1. PCR-based
Molecular Assays
15.7.2.1.1.1.1. Real-time PCR
15.7.2.1.1.1.2. Sequence Specific Primers-PCR
15.7.2.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.2.1.1.1.4. Others
15.7.2.1.1.2. Sequencing-based
Molecular Assays
15.7.2.1.2. Sanger Sequencing
15.7.2.1.3. Non-molecular Assay Technologies
15.7.2.2. Japan Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
15.7.2.2.1. Reagents and Consumables
15.7.2.2.2. Instruments
15.7.2.2.3. Software and Services
15.7.2.3. Japan Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.2.3.1. Diagnostic Applications
15.7.2.3.2. Research Applications
15.7.2.4. Japan Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
15.7.2.4.1. Solid Organ
15.7.2.4.2. Stem Cell
15.7.2.4.3. Soft Tissue
15.7.2.5. Japan Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
15.7.2.5.1. Independent Reference Laboratories
15.7.2.5.2. Hospitals and Transplant Centers
15.7.2.5.3. Research Laboratories and Academic Institutes
15.7.3. India
15.7.3.1. India Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
15.7.3.1.1. Molecular Assay Technologies
15.7.3.1.1.1. PCR-based
Molecular Assays
15.7.3.1.1.1.1. Real-time PCR
15.7.3.1.1.1.2. Sequence Specific Primers-PCR
15.7.3.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.3.1.1.1.4. Others
15.7.3.1.1.2. Sequencing-based
Molecular Assays
15.7.3.1.2. Sanger Sequencing
15.7.3.1.3. Non-molecular Assay Technologies
15.7.3.2. India Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
15.7.3.2.1. Reagents and Consumables
15.7.3.2.2. Instruments
15.7.3.2.3. Software and Services
15.7.3.3. India Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.3.3.1. Diagnostic Applications
15.7.3.3.2. Research Applications
15.7.3.4. India Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
15.7.3.4.1. Solid Organ
15.7.3.4.2. Stem Cell
15.7.3.4.3. Soft Tissue
15.7.3.5. India Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
15.7.3.5.1. Independent Reference Laboratories
15.7.3.5.2. Hospitals and Transplant Centers
15.7.3.5.3. Research Laboratories and Academic Institutes
15.7.4. New
Zealand
15.7.4.1. New Zealand Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Technology Type
15.7.4.1.1. Molecular Assay Technologies
15.7.4.1.1.1. PCR-based
Molecular Assays
15.7.4.1.1.1.1. Real-time PCR
15.7.4.1.1.1.2. Sequence Specific Primers-PCR
15.7.4.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.4.1.1.1.4. Others
15.7.4.1.1.2. Sequencing-based
Molecular Assays
15.7.4.1.2. Sanger Sequencing
15.7.4.1.3. Non-molecular Assay Technologies
15.7.4.2. New Zealand Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Product
15.7.4.2.1. Reagents and Consumables
15.7.4.2.2. Instruments
15.7.4.2.3. Software and Services
15.7.4.3. New Zealand Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.4.3.1. Diagnostic Applications
15.7.4.3.2. Research Applications
15.7.4.4. New Zealand Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Transplant Type
15.7.4.4.1. Solid Organ
15.7.4.4.2. Stem Cell
15.7.4.4.3. Soft Tissue
15.7.4.5. New Zealand Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By End User
15.7.4.5.1. Independent Reference Laboratories
15.7.4.5.2. Hospitals and Transplant Centers
15.7.4.5.3. Research Laboratories and Academic Institutes
15.7.5. Australia
15.7.5.1. Australia Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Technology Type
15.7.5.1.1. Molecular Assay Technologies
15.7.5.1.1.1. PCR-based
Molecular Assays
15.7.5.1.1.1.1. Real-time PCR
15.7.5.1.1.1.2. Sequence Specific Primers-PCR
15.7.5.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.5.1.1.1.4. Others
15.7.5.1.1.2. Sequencing-based
Molecular Assays
15.7.5.1.2. Sanger Sequencing
15.7.5.1.3. Non-molecular Assay Technologies
15.7.5.2. Australia Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Product
15.7.5.2.1. Reagents and Consumables
15.7.5.2.2. Instruments
15.7.5.2.3. Software and Services
15.7.5.3. Australia Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.5.3.1. Diagnostic Applications
15.7.5.3.2. Research Applications
15.7.5.4. Australia Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Transplant Type
15.7.5.4.1. Solid Organ
15.7.5.4.2. Stem Cell
15.7.5.4.3. Soft Tissue
15.7.5.5. Australia Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By End User
15.7.5.5.1. Independent Reference Laboratories
15.7.5.5.2. Hospitals and Transplant Centers
15.7.5.5.3. Research Laboratories and Academic Institutes
15.7.6. South
Korea
15.7.6.1. South Korea Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Technology Type
15.7.6.1.1. Molecular Assay Technologies
15.7.6.1.1.1. PCR-based
Molecular Assays
15.7.6.1.1.1.1. Real-time PCR
15.7.6.1.1.1.2. Sequence Specific Primers-PCR
15.7.6.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.6.1.1.1.4. Others
15.7.6.1.1.2. Sequencing-based
Molecular Assays
15.7.6.1.2. Sanger Sequencing
15.7.6.1.3. Non-molecular Assay Technologies
15.7.6.2. South Korea Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Product
15.7.6.2.1. Reagents and Consumables
15.7.6.2.2. Instruments
15.7.6.2.3. Software and Services
15.7.6.3. South Korea Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.6.3.1. Diagnostic Applications
15.7.6.3.2. Research Applications
15.7.6.4. South Korea Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Transplant Type
15.7.6.4.1. Solid Organ
15.7.6.4.2. Stem Cell
15.7.6.4.3. Soft Tissue
15.7.6.5. South Korea Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By End User
15.7.6.5.1. Independent Reference Laboratories
15.7.6.5.2. Hospitals and Transplant Centers
15.7.6.5.3. Research Laboratories and Academic Institutes
15.7.7. Southeast
Asia
15.7.7.1. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Technology Type
15.7.7.1.1. Molecular Assay Technologies
15.7.7.1.1.1. PCR-based
Molecular Assays
15.7.7.1.1.1.1. Real-time PCR
15.7.7.1.1.1.2. Sequence Specific Primers-PCR
15.7.7.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.7.1.1.1.4. Others
15.7.7.1.1.2. Sequencing-based
Molecular Assays
15.7.7.1.2. Sanger Sequencing
15.7.7.1.3. Non-molecular Assay Technologies
15.7.7.2. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Product
15.7.7.2.1. Reagents and Consumables
15.7.7.2.2. Instruments
15.7.7.2.3. Software and Services
15.7.7.3. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Application
15.7.7.3.1. Diagnostic Applications
15.7.7.3.2. Research Applications
15.7.7.4. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Transplant Type
15.7.7.4.1. Solid Organ
15.7.7.4.2. Stem Cell
15.7.7.4.3. Soft Tissue
15.7.7.5. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By End User
15.7.7.5.1. Independent Reference Laboratories
15.7.7.5.2. Hospitals and Transplant Centers
15.7.7.5.3. Research Laboratories and Academic Institutes
15.7.7.6. Southeast Asia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest of Asia Pacific Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Technology Type
15.7.8.1.1. Molecular Assay Technologies
15.7.8.1.1.1. PCR-based
Molecular Assays
15.7.8.1.1.1.1. Real-time PCR
15.7.8.1.1.1.2. Sequence Specific Primers-PCR
15.7.8.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
15.7.8.1.1.1.4. Others
15.7.8.1.1.2. Sequencing-based
Molecular Assays
15.7.8.1.2. Sanger Sequencing
15.7.8.1.3. Non-molecular Assay Technologies
15.7.8.2. Rest of Asia Pacific Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Product
15.7.8.2.1. Reagents and Consumables
15.7.8.2.2. Instruments
15.7.8.2.3. Software and Services
15.7.8.3. Rest of Asia Pacific Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Application
15.7.8.3.1. Diagnostic Applications
15.7.8.3.2. Research Applications
15.7.8.4. Rest of Asia Pacific Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By Transplant Type
15.7.8.4.1. Solid Organ
15.7.8.4.2. Stem Cell
15.7.8.4.3. Soft Tissue
15.7.8.5. Rest of Asia Pacific Transplant Monitoring Kits Market Revenue
(US$ Mn) and Forecasts, By End User
15.7.8.5.1. Independent Reference Laboratories
15.7.8.5.2. Hospitals and Transplant Centers
15.7.8.5.3. Research Laboratories and Academic Institutes
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By
Technology Type
15.8.3. By
Product
15.8.4. By
Application
15.8.5. By
Transplant Type
15.8.6. By End
User
16. Middle East and Africa Transplant Monitoring Kits Market
Analysis and Forecasts, 2023 – 2031
16.1. Overview
16.1.1. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn)
16.2. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
16.2.1. Molecular
Assay Technologies
16.2.1.1. PCR-based Molecular Assays
16.2.1.1.1. Real-time PCR
16.2.1.1.2. Sequence Specific Primers-PCR
16.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.2.1.1.4. Others
16.2.1.2. Sequencing-based Molecular Assays
16.2.2. Sanger
Sequencing
16.2.3. Non-molecular
Assay Technologies
16.3. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
16.3.1. Reagents
and Consumables
16.3.2. Instruments
16.3.3. Software
and Services
16.4. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
16.4.1. Diagnostic
Applications
16.4.2. Research
Applications
16.5. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
16.5.1. Solid
Organ
16.5.2. Stem
Cell
16.5.3. Soft
Tissue
16.6. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1. Independent
Reference Laboratories
16.6.2. Hospitals
and Transplant Centers
16.6.3. Research
Laboratories and Academic Institutes
16.7. Middle
East and Africa Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi Arabia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Technology Type
16.7.1.1.1. Molecular Assay Technologies
16.7.1.1.1.1. PCR-based
Molecular Assays
16.7.1.1.1.1.1. Real-time PCR
16.7.1.1.1.1.2. Sequence Specific Primers-PCR
16.7.1.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.1.1.1.1.4. Others
16.7.1.1.1.2. Sequencing-based
Molecular Assays
16.7.1.1.2. Sanger Sequencing
16.7.1.1.3. Non-molecular Assay Technologies
16.7.1.2. Saudi Arabia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Product
16.7.1.2.1. Reagents and Consumables
16.7.1.2.2. Instruments
16.7.1.2.3. Software and Services
16.7.1.3. Saudi Arabia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Application
16.7.1.3.1. Diagnostic Applications
16.7.1.3.2. Research Applications
16.7.1.4. Saudi Arabia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Transplant Type
16.7.1.4.1. Solid Organ
16.7.1.4.2. Stem Cell
16.7.1.4.3. Soft Tissue
16.7.1.5. Saudi Arabia Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By End User
16.7.1.5.1. Independent Reference Laboratories
16.7.1.5.2. Hospitals and Transplant Centers
16.7.1.5.3. Research Laboratories and Academic Institutes
16.7.2. UAE
16.7.2.1. UAE Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
16.7.2.1.1. Molecular Assay Technologies
16.7.2.1.1.1. PCR-based
Molecular Assays
16.7.2.1.1.1.1. Real-time PCR
16.7.2.1.1.1.2. Sequence Specific Primers-PCR
16.7.2.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.2.1.1.1.4. Others
16.7.2.1.1.2. Sequencing-based
Molecular Assays
16.7.2.1.2. Sanger Sequencing
16.7.2.1.3. Non-molecular Assay Technologies
16.7.2.2. UAE Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
16.7.2.2.1. Reagents and Consumables
16.7.2.2.2. Instruments
16.7.2.2.3. Software and Services
16.7.2.3. UAE Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.2.3.1. Diagnostic Applications
16.7.2.3.2. Research Applications
16.7.2.4. UAE Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
16.7.2.4.1. Solid Organ
16.7.2.4.2. Stem Cell
16.7.2.4.3. Soft Tissue
16.7.2.5. UAE Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
16.7.2.5.1. Independent Reference Laboratories
16.7.2.5.2. Hospitals and Transplant Centers
16.7.2.5.3. Research Laboratories and Academic Institutes
16.7.3. Egypt
16.7.3.1. Egypt Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
16.7.3.1.1. Molecular Assay Technologies
16.7.3.1.1.1. PCR-based
Molecular Assays
16.7.3.1.1.1.1. Real-time PCR
16.7.3.1.1.1.2. Sequence Specific Primers-PCR
16.7.3.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.3.1.1.1.4. Others
16.7.3.1.1.2. Sequencing-based
Molecular Assays
16.7.3.1.2. Sanger Sequencing
16.7.3.1.3. Non-molecular Assay Technologies
16.7.3.2. Egypt Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
16.7.3.2.1. Reagents and Consumables
16.7.3.2.2. Instruments
16.7.3.2.3. Software and Services
16.7.3.3. Egypt Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.3.3.1. Diagnostic Applications
16.7.3.3.2. Research Applications
16.7.3.4. Egypt Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
16.7.3.4.1. Solid Organ
16.7.3.4.2. Stem Cell
16.7.3.4.3. Soft Tissue
16.7.3.5. Egypt Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
16.7.3.5.1. Independent Reference Laboratories
16.7.3.5.2. Hospitals and Transplant Centers
16.7.3.5.3. Research Laboratories and Academic Institutes
16.7.4. Kuwait
16.7.4.1. Kuwait Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
16.7.4.1.1. Molecular Assay Technologies
16.7.4.1.1.1. PCR-based
Molecular Assays
16.7.4.1.1.1.1. Real-time PCR
16.7.4.1.1.1.2. Sequence Specific Primers-PCR
16.7.4.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.4.1.1.1.4. Others
16.7.4.1.1.2. Sequencing-based
Molecular Assays
16.7.4.1.2. Sanger Sequencing
16.7.4.1.3. Non-molecular Assay Technologies
16.7.4.2. Kuwait Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
16.7.4.2.1. Reagents and Consumables
16.7.4.2.2. Instruments
16.7.4.2.3. Software and Services
16.7.4.3. Kuwait Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.4.3.1. Diagnostic Applications
16.7.4.3.2. Research Applications
16.7.4.4. Kuwait Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
16.7.4.4.1. Solid Organ
16.7.4.4.2. Stem Cell
16.7.4.4.3. Soft Tissue
16.7.4.5. Kuwait Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
16.7.4.5.1. Independent Reference Laboratories
16.7.4.5.2. Hospitals and Transplant Centers
16.7.4.5.3. Research Laboratories and Academic Institutes
16.7.5. South
Africa
16.7.5.1. South Africa Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Technology Type
16.7.5.1.1. Molecular Assay Technologies
16.7.5.1.1.1. PCR-based
Molecular Assays
16.7.5.1.1.1.1. Real-time PCR
16.7.5.1.1.1.2. Sequence Specific Primers-PCR
16.7.5.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.5.1.1.1.4. Others
16.7.5.1.1.2. Sequencing-based
Molecular Assays
16.7.5.1.2. Sanger Sequencing
16.7.5.1.3. Non-molecular Assay Technologies
16.7.5.2. South Africa Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Product
16.7.5.2.1. Reagents and Consumables
16.7.5.2.2. Instruments
16.7.5.2.3. Software and Services
16.7.5.3. South Africa Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Application
16.7.5.3.1. Diagnostic Applications
16.7.5.3.2. Research Applications
16.7.5.4. South Africa Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By Transplant Type
16.7.5.4.1. Solid Organ
16.7.5.4.2. Stem Cell
16.7.5.4.3. Soft Tissue
16.7.5.5. South Africa Transplant Monitoring Kits Market Revenue (US$
Mn) and Forecasts, By End User
16.7.5.5.1. Independent Reference Laboratories
16.7.5.5.2. Hospitals and Transplant Centers
16.7.5.5.3. Research Laboratories and Academic Institutes
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Transplant Monitoring Kits
Market Revenue (US$ Mn) and Forecasts, By Technology Type
16.7.6.1.1. Molecular Assay Technologies
16.7.6.1.1.1. PCR-based
Molecular Assays
16.7.6.1.1.1.1. Real-time PCR
16.7.6.1.1.1.2. Sequence Specific Primers-PCR
16.7.6.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
16.7.6.1.1.1.4. Others
16.7.6.1.1.2. Sequencing-based
Molecular Assays
16.7.6.1.2. Sanger Sequencing
16.7.6.1.3. Non-molecular Assay Technologies
16.7.6.2. Rest of Middle East & Africa Transplant Monitoring Kits
Market Revenue (US$ Mn) and Forecasts, By Product
16.7.6.2.1. Reagents and Consumables
16.7.6.2.2. Instruments
16.7.6.2.3. Software and Services
16.7.6.3. Rest of Middle East & Africa Transplant Monitoring Kits
Market Revenue (US$ Mn) and Forecasts, By Application
16.7.6.3.1. Diagnostic Applications
16.7.6.3.2. Research Applications
16.7.6.4. Rest of Middle East & Africa Transplant Monitoring Kits
Market Revenue (US$ Mn) and Forecasts, By Transplant Type
16.7.6.4.1. Solid Organ
16.7.6.4.2. Stem Cell
16.7.6.4.3. Soft Tissue
16.7.6.5. Rest of Middle East & Africa Transplant Monitoring Kits
Market Revenue (US$ Mn) and Forecasts, By End User
16.7.6.5.1. Independent Reference Laboratories
16.7.6.5.2. Hospitals and Transplant Centers
16.7.6.5.3. Research Laboratories and Academic Institutes
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Technology Type
16.8.3. By
Product
16.8.4. By
Application
16.8.5. By
Transplant Type
16.8.6. By End
User
17. Latin America Transplant Monitoring Kits Market Analysis and
Forecasts, 2023 – 2031
17.1. Overview
17.1.1. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn)
17.2. Latin America
Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By Technology
Type
17.2.1. Molecular
Assay Technologies
17.2.1.1. PCR-based Molecular Assays
17.2.1.1.1. Real-time PCR
17.2.1.1.2. Sequence Specific Primers-PCR
17.2.1.1.3. Sequence-Specific Oligonucleotide-PCR
17.2.1.1.4. Others
17.2.1.2. Sequencing-based Molecular Assays
17.2.2. Sanger
Sequencing
17.2.3. Non-molecular
Assay Technologies
17.3. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Product
17.3.1. Reagents
and Consumables
17.3.2. Instruments
17.3.3. Software
and Services
17.4. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Application
17.4.1. Diagnostic
Applications
17.4.2. Research
Applications
17.5. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Transplant Type
17.5.1. Solid
Organ
17.5.2. Stem
Cell
17.5.3. Soft Tissue
17.6. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
End User
17.6.1. Independent
Reference Laboratories
17.6.2. Hospitals
and Transplant Centers
17.6.3. Research
Laboratories and Academic Institutes
17.7. Latin
America Transplant Monitoring Kits Market Revenue (US$ Mn) and Forecasts, By
Country
17.7.1. Brazil
17.7.1.1. Brazil Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Technology Type
17.7.1.1.1. Molecular Assay Technologies
17.7.1.1.1.1. PCR-based
Molecular Assays
17.7.1.1.1.1.1. Real-time PCR
17.7.1.1.1.1.2. Sequence Specific Primers-PCR
17.7.1.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
17.7.1.1.1.1.4. Others
17.7.1.1.1.2. Sequencing-based
Molecular Assays
17.7.1.1.2. Sanger Sequencing
17.7.1.1.3. Non-molecular Assay Technologies
17.7.1.2. Brazil Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Product
17.7.1.2.1. Reagents and Consumables
17.7.1.2.2. Instruments
17.7.1.2.3. Software and Services
17.7.1.3. Brazil Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.1.3.1. Diagnostic Applications
17.7.1.3.2. Research Applications
17.7.1.4. Brazil Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By Transplant Type
17.7.1.4.1. Solid Organ
17.7.1.4.2. Stem Cell
17.7.1.4.3. Soft Tissue
17.7.1.5. Brazil Transplant Monitoring Kits Market Revenue (US$ Mn) and
Forecasts, By End User
17.7.1.5.1. Independent Reference Laboratories
17.7.1.5.2. Hospitals and Transplant Centers
17.7.1.5.3. Research Laboratories and Academic Institutes
17.7.2. Argentina
17.7.2.1. Argentina Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Technology Type
17.7.2.1.1. Molecular Assay Technologies
17.7.2.1.1.1. PCR-based
Molecular Assays
17.7.2.1.1.1.1. Real-time PCR
17.7.2.1.1.1.2. Sequence Specific Primers-PCR
17.7.2.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
17.7.2.1.1.1.4. Others
17.7.2.1.1.2. Sequencing-based
Molecular Assays
17.7.2.1.2. Sanger Sequencing
17.7.2.1.3. Non-molecular Assay Technologies
17.7.2.2. Argentina Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Product
17.7.2.2.1. Reagents and Consumables
17.7.2.2.2. Instruments
17.7.2.2.3. Software and Services
17.7.2.3. Argentina Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Application
17.7.2.3.1. Diagnostic Applications
17.7.2.3.2. Research Applications
17.7.2.4. Argentina Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By Transplant Type
17.7.2.4.1. Solid Organ
17.7.2.4.2. Stem Cell
17.7.2.4.3. Soft Tissue
17.7.2.5. Argentina Transplant Monitoring Kits Market Revenue (US$ Mn)
and Forecasts, By End User
17.7.2.5.1. Independent Reference Laboratories
17.7.2.5.2. Hospitals and Transplant Centers
17.7.2.5.3. Research Laboratories and Academic Institutes
17.7.3. Rest of
Latin America
17.7.3.1. Rest of Latin America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Technology Type
17.7.3.1.1. Molecular Assay Technologies
17.7.3.1.1.1. PCR-based
Molecular Assays
17.7.3.1.1.1.1. Real-time PCR
17.7.3.1.1.1.2. Sequence Specific Primers-PCR
17.7.3.1.1.1.3. Sequence-Specific Oligonucleotide-PCR
17.7.3.1.1.1.4. Others
17.7.3.1.1.2. Sequencing-based
Molecular Assays
17.7.3.1.2. Sanger Sequencing
17.7.3.1.3. Non-molecular Assay Technologies
17.7.3.2. Rest of Latin America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Product
17.7.3.2.1. Reagents and Consumables
17.7.3.2.2. Instruments
17.7.3.2.3. Software and Services
17.7.3.3. Rest of Latin America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Application
17.7.3.3.1. Diagnostic Applications
17.7.3.3.2. Research Applications
17.7.3.4. Rest of Latin America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By Transplant Type
17.7.3.4.1. Solid Organ
17.7.3.4.2. Stem Cell
17.7.3.4.3. Soft Tissue
17.7.3.5. Rest of Latin America Transplant Monitoring Kits Market
Revenue (US$ Mn) and Forecasts, By End User
17.7.3.5.1. Independent Reference Laboratories
17.7.3.5.2. Hospitals and Transplant Centers
17.7.3.5.3. Research Laboratories and Academic Institutes
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Technology Type
17.8.3. By
Product
17.8.4. By
Application
17.8.5. By
Transplant Type
17.8.6. By End
User
18. Competitive Benchmarking
18.1. Brand
Benchmarking
18.2. Market
Share Analysis, 2020
18.3. Global
Presence and Growth Strategies
18.3.1. Mergers
and Acquisitions
18.3.2. Product
Launches
18.3.3. Investments
Trends
18.3.4. R&D
Initiatives
19. Player Profiles
19.1. Biocare
Health Resources, Inc.
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Biogenuix
Medsystems Pvt. Ltd
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. Bio-Rad
Laboratories, Inc.
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. CareDx,
Inc.
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. ELITech
Group
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Eurofins
Scientific
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. F.
Hoffmann-La Roche Ltd
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Genome
Diagnostics B.V.
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Hologic,
Inc.
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. JETA
Molecular BV.
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Natera,
Inc.
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. QIAGEN
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business
Strategies
19.13. SanBio
Co,Ltd.
19.13.1. Company
Details
19.13.2. Company
Overview
19.13.3. Product
Offerings
19.13.4. Key
Developments
19.13.5. Financial
Analysis
19.13.6. SWOT
Analysis
19.13.7. Business
Strategies
19.14. Thermo
Fisher Scientific Inc.
19.14.1. Company
Details
19.14.2. Company
Overview
19.14.3. Product
Offerings
19.14.4. Key
Developments
19.14.5. Financial
Analysis
19.14.6. SWOT
Analysis
19.14.7. Business Strategies
19.15. Other
market participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.